• Air Pollution in London Is Enough to Counter Exercise Benefits in Older Adults, Study Finds
  • Phase 4 Trial Finds Tudorza Safe and Effective for COPD Patients with Cardiovascular Disease
  • New Tool Needed to Better Select COPD Patients for Lung Transplant, Study Suggests
  • Cancer Risk Jumps After COPD Patient Has Lung Transplant, Sweden Study Reports
  • Switching from Seretide to Ultibro Breezhaler Seen to Be Safe, Effective in COPD Patients
  • Propeller Health, Express Scripts Collaborate on Digital Respiratory Care for COPD and Asthma Patients
  • Partners Theravance and Mylin Submit New Drug Application for Revefenacin as COPD Treatment
  • Boehringer Ingelheim to Host Live Event on Facebook, Twitter for Nov. 15, World COPD Day
  • Enrollment for Phase 2b Trial of Verona’s COPD Therapy RPL554 Is Ahead of Schedule
  • Anoro Ellipta Outperforms Stiolto Respimat in Improving Lung Function, Study Finds
  • Pivotal Phase 3 Trials Demonstrate SUN-101/eFlow is Safe, Effective, Analyses Show
  • COPD Foundation, Geisinger, GSK, and Jvion Join Forces in Machine Learning Initiative